EQL Pharma AB (publ) reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was SEK 117.61 million compared to SEK 29.61 million a year ago. Net income was SEK 17.2 million compared to SEK 2.17 million a year ago. Basic earnings per share from continuing operations was SEK 0.59 compared to SEK 0.07 a year ago.
For the nine months, sales was SEK 206.73 million compared to SEK 153.34 million a year ago. Net income was SEK 25.04 million compared to SEK 16.61 million a year ago. Basic earnings per share from continuing operations was SEK 0.86 compared to SEK 0.57 a year ago.